Clinical Trial Update: Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer

View source ↗

Summary

A completed clinical trial evaluated the effect of paclitaxel/cisplatin chemotherapy on development of dysgeusia in patients with non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysgeusia
• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Instituto Nacional de Cancerologia de Mexico | Conditions: Non-Small Cell Lung Cancer, Dysgeusia | Status: COMPLETED | Results posted: 2015-03-18